Researchers in a recent breakthrough have identified a better and more advanced way to examine cancer biopsies by using ...
Today at the San Antonio Breast Cancer Symposium (SABCS), researchers presented the initial findings from a major multi-year collaboration between the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and ...
A tumor-informed ctDNA assay identified MRD in TNBC patients, indicating a 30-fold higher risk of distant recurrence for MRD-positive individuals. The NSABP B-59/GBG 96-GeparDouze trial involved 1550 ...
Evvy’s new UTI+ Test and microbiome tools deliver faster, clearer insights into BV and UTI care, reshaping women’s health ...
The tool scans digital images of the same cancer tissue samples that pathologists use and can tell how fast the cancer is ...
Prelude Corporation (PreludeDx®), a leader in precision diagnostics for early-stage breast cancer, today announced results from the first independent validation of AidaBreasttm, a novel multi-omic ...
Artificial intelligence is revolutionizing drug discovery and antibody engineering, accelerating the creation of new ...
What if a single intervention could lower the risk of developing cancer, help treatment work better, lessen side effects, boost mental health and even reduce the risk of disease recurrence and death?
Tepper’s point is that it “doesn’t mean that Taylor Swift is a Nazi, but it also doesn’t mean that there is no significance ...
An AI-driven computational toolkit, Gcoupler, integrates ligand design, statistical modeling, and graph neural networks to predict endogenous metabolites that allosterically modulate the GPCR–Gα ...
Non-cystic fibrosis bronchiectasis (NCFB) is a heterogeneous disease characterised by a ‘vicious vortex’ of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback